Status:
COMPLETED
Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol
Lead Sponsor:
Aarhus University Hospital
Conditions:
Acute Lymphoblastic Leukemia
Post Thrombotic Syndrome
Eligibility:
All Genders
1+ years
Brief Summary
Acute lymphoblastic leukemia (ALL) is the most common malignant disease in childhood. Today more than 90% of children and 75% of adults (18-45 years) survive ALL. The enzyme Asparaginase (Asp) is an i...
Eligibility Criteria
Inclusion
- Treated on the ALL2008 protocol for ALL. Had a DVT on treatment.
Exclusion
- Death
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04825548
Start Date
July 1 2020
End Date
December 31 2023
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus N, Vælg En Region, Stat Eller Provins., Denmark, 8200